Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) EPS (Weighted Average and Diluted): 2013-2024

Historic EPS (Weighted Average and Diluted) for Armata Pharmaceuticals (ARMP) over the last 12 years, with Dec 2024 value amounting to -$0.89.

  • Armata Pharmaceuticals' EPS (Weighted Average and Diluted) rose 32.28% to -$0.24 in Q4 2018 from the same period last year, while for Dec 2018 it was -$3.27, marking a year-over-year increase of 63.72%. This contributed to the annual value of -$0.89 for FY2024, which is 53.40% up from last year.
  • Per Armata Pharmaceuticals' latest filing, its EPS (Weighted Average and Diluted) stood at -$0.89 for FY2024, which was up 53.40% from -$1.91 recorded in FY2023.
  • In the past 5 years, Armata Pharmaceuticals' EPS (Weighted Average and Diluted) ranged from a high of -$0.89 in FY2024 and a low of -$1.91 during FY2023.
  • Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was -$1.08 (2022), whereas its average is -$1.29.
  • Per our database at Business Quant, Armata Pharmaceuticals' EPS (Weighted Average and Diluted) tumbled by 76.85% in 2023 and then soared by 53.40% in 2024.
  • Yearly analysis of 5 years shows Armata Pharmaceuticals' EPS (Weighted Average and Diluted) stood at -$1.35 in 2020, then grew by 28.89% to -$0.96 in 2021, then dropped by 12.50% to -$1.08 in 2022, then plummeted by 76.85% to -$1.91 in 2023, then surged by 53.40% to -$0.89 in 2024.